The 3^rd Obesity & Weight Loss Summit has been announced and is set to ignite the field.  The summit will unite experts to harness novel targets and GLP combination therapies to improve efficacy, tolerability, and longer lasting clinical outcomes.

Join us at this unique, industry-led summit to:

• Discover groundbreaking combination therapies and novel targets to minimize and manage side effects to improve patient tolerability with Boehringer Ingelheim and Altimmune
• Explore innovative approaches for preserving muscle mass whilst still achieving significant weight loss to prevent sarcopenia with Regeneron and iBio
• Investigate cutting-edge advancements in drug delivery technologies, including long-acting formulations and novel administration routes for simpler patient use with Biolexis and Syntis Bio
• Learn strategies to drive long-term weight management success by personalizing treatment for more prolonged patient continuation and satisfaction with Prive Bio and Fractyl Therapeutic

Hear from the titans of the pharmaceutical industry – Eli Lilly, Novo Nordisk, AstraZeneca, Altimmune, High Tide Therapeutics, RenBio, and many more – as they share their groundbreaking research and strategies for developing more effective, tolerable, and long-lasting weight management solutions.

Obesity rates are increasing, and the pressure is on for real change. Don’t miss this pivotal opportunity to network with 70+ obesity scientists and drug development experts forge collaborations, and be part of the solution. The future of weight loss treatment is being written now – be there!

For more information, view the full Event Guide here: https://ter.li/rish42